Stock BXP BEXIMCO PHARMACEUTICALS LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

All News Beximco Pharmaceuticals Limited London S.E.

Equities

BXP

US0885792061

Market Closed - London S.E.
Other stock markets
 11:35:08 2024-05-03 am EDT 		5-day change 1st Jan Change
37.5 GBX +2.74% Intraday chart for Beximco Pharmaceuticals Limited +2.74% -9.64%
Apr. 30 EARNINGS AND TRADING: Software Circle & Beximco report higher revenue AN
Apr. 30 Beximco Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2024 CI

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
EARNINGS AND TRADING: Software Circle & Beximco report higher revenue
AN
Beximco Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2024
CI
Beximco names Iqbal Ahmed as managing director
AN
Beximco Pharmaceuticals to strengthen portfolio as interim profit up
AN
Beximco Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended December 30, 2023
CI
Beximco Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023
CI
Beximco MD steps down to join Bangladeshi cabinet
AN
Beximco Pharmaceuticals Limited Announces Stepping Down of Mr. Nazmul Hassan as Member of the Board
CI
Beximco Pharmaceuticals Limited Announces Stepping Down of Mr. Nazmul Hassan as Managing Director
CI
Ex-dividend day for final dividend
FA
Beximco Pharmaceuticals Posts Higher Fiscal Q1 Profit, Revenue
MT
Beximco Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended September 30, 2023
CI
Beximco boosts revenue in local currency but profit falls
AN
Beximco Pharmaceuticals Limited Reports Earnings Results for the Full Year Ended June 30, 2023
CI
Beximco Pharmaceuticals Limited Proposes Dividend for the Year Ended June 30, 2023
CI
Beximco working to fix deficiencies at manufacturing plant
AN
Beximco Pharmaceuticals to Tackle Ophthalmic Manufacturing Unit Deficiencies After Malta Medicines Authority Audit
MT
EARNINGS UPDATES: HC Slingsby profit falls, East Imperial loss narrows
AN
Beximco Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2023
CI
TRADING UPDATES: Ferro-Alloy eyes revenue to drop below market view
AN
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. BXPHARMA Stock
  4. BXP Stock
  5. News Beximco Pharmaceuticals Limited